BioNTech's Withdrawal from Germany Raises Vaccine Supply Concerns

An expert advises the German federal government to assess vaccine capacities for potential crises, following BioNTech's withdrawal from Germany, with allegations of deception also surfacing from the acquired company Curevac.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

der-standardGerman2h ago

Mögliche Engpässe durch Biontech-Rückzug aus Deutschland

Experte rät Bundesregierung, Kapazitäten für Impfstoffe für Krisenfall zu prüfen. Auch Vorwürfe der Täuschung vom übernommenen Unternehmen Curevac stehen im Raum

Read full article →

PERSPECTA

PERSPECTA

BioNTech's Withdrawal from Germany Raises Vaccine Supply Concerns

Sources

Mögliche Engpässe durch Biontech-Rückzug aus Deutschland

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

Domestic Workers in Zamboanga Peninsula to Receive Wage Hikes

Optimism Grows for US-Iran Deal Amid Hormuz Tensions

Nigerian firm arraigned for illegal rebroadcast of MultiChoice content

PERSPECTA